Synergy Innovation Co., Ltd. (048870.KQ)

2,495.00 -65.00 (-2.54%) At close: 03:30PM KST

Synergy Innovation Co., Ltd.

52, Sagimakgol-ro
5F Suntech City II Jungwon-gu
Seongnam-Si 13210
South Korea
82 3 1746 2560
https://www.synergyinno.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Han-Ki Kim	Chief Executive Officer	N/A	N/A	1960
Mr. Gil Hwan Ahn	Chief Financial Officer, Vice President and Executive Director	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.

Corporate governance

Synergy Innovation Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.